Telemynd.png
MYnd Analytics, Inc. Announces Ticker Symbol Change to "MYAN"
11 oct. 2016 14h45 HE | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 11, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), which provides a unique set of reference data and analytic tools for clinicians to assist...
Telemynd.png
MYnd Analytics California Centers Receive CMS Approval
10 oct. 2016 05h00 HE | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSOD), which provides a unique set of reference data and analytic tools for clinicians to assist in...
Telemynd.png
EEG is the Wave of the Future: Machine Learning Technology Highlighted in Biological Psychiatry Publication
27 sept. 2016 20h00 HE | MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSOD) announces the publication of “Using Electroencephalography for Treatment Guidance in Major Depressive...
Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
13 mai 2015 09h17 HE | Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
11 mars 2015 08h02 HE | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
17 nov. 2014 08h02 HE | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...
DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference
10 juil. 2014 08h02 HE | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Presentation at the 2014 BIO International Convention
18 juin 2014 08h00 HE | DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - June 18, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
28 mai 2014 05h00 HE | Provista Diagnostics, Inc.
NEW YORK, NY, May 28, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests...